Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice

Stem Cells

Volumn 27, Issue 8, 2009, Pages 1999-2008

  Kang, Hyun Mi ^a   Kim, Jiyoung ^a   Park, Seah ^a   Kim, Jinyoung ^a   Kim, Haekwon ^a   Kim, Kyung Sik ^b   Lee, Eun Jig ^b   Seo, Sung Ig ^c   Kang, Sung Goo ^d   Lee, Jong Eun ^e   Lim, Hyunjung ^e  

^a Seoul Women University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Sein Aesthetic Plastic Surgery Clinic   (South Korea)

^d Inje University   (South Korea)

^e Konkuk University   (South Korea)

Author keywords

cell; Human eyelid adipose; Immunocompetent; Insulin; Stem cell; Type I diabetes

Indexed keywords

ACTIVIN; C PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HUMAN INSULIN; INSULIN; NICOTINAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; EYELID DERIVED STEM CELL; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MALE; NEURAL CREST LIKE STEM CELL; PANCREAS ISLET BETA CELL; PROTEIN LOCALIZATION; SCHOOL CHILD; STEM CELL; STEM CELL TRANSPLANTATION; STREPTOZOCIN DIABETES;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHILD; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; EYELIDS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; MIDDLE AGED; STEM CELL TRANSPLANTATION; STEM CELLS; YOUNG ADULT;

ANIMALIA; MUS;

EID: 69249159949     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.127     Document Type: Article

References (50)

1. Tang DQ, Cao LZ, Burkhardt BR et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004;53:1721-1732.
2. Oh SH, Muzzonigro TM, Bae SH et al. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest 2004;84:607-617.
3. Lumelsky N, Blondel O, Laeng P et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389-1394.
4. Hori Y, Rulifson IC, Tsai BC et al. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A 2002;99:16105-16110.
5. Sapir T, Shternhall K, Meivar-Levy I et al. Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proc Natl Acad Sci U S A 2005;102:7964-7969.
6. Zalzman M, Anker-Kitai L, Efrat S. Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype. Diabetes 2005;54:2568-2575.
7. Ruhnke M, Ungefroren H, Nussler A et al. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 2005;128:1774-1786.
8. Chao KC, Chao KF, Fu YS et al. Islet-like clusters derived from mesenchymal stem cells in Wharton's jelly of the human umbilical cord for transplantation to control type 1 diabetes. Plos One 2008;3:e1451.
9. Hess D, Li L, Martin M et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003;21:763-770.
10. Urbán VS, Kiss J, Kovács J et al. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 2008;26:244-253.
11. Kodama S, Kühtreiber W, Fujimura S et al. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003;302:1223-1227.
12. Lee RH, Seo MJ, Reger RL et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 2006;103:17438-17443.
13. Crane JF, Trainor PA. Neural crest stem and progenitor cells. Annu Rev Cell Dev Biol 2006;22:267-286. Review.
14. Miura M, Gronthos S, Zhao M et al. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A 2003;100:5807-5812.
15. Ikeda E, Yagi K, Kojima M et al. Multipotent cells from the human third molar: feasibility of cell-based therapy for liver disease. Differentiation 2008;76:495-505.
16. Liechty KW, MacKenzie TC, Shaaban AF et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6:1282-1286.
17. Abraham EJ, Kodama S, Lin JC et al. Human pancreatic islet-derived progenitor cell engraftment in immunocompetent mice. Am J Pathol 2004;164:817-830.
18. Rodriguez AM, Pisani D, Dechesne CA et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 2005;20:1397-1405.
19. Cristofalo VJ, Allen RG, Pignolo RJ et al. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci U S A 1998;95:10614-10619.
20. Kim J, Lee Y, Kim H et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007;40:75-90.
21. Chang CM, Kao CL, Chang YL et al. Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells. Biochem Biophys Res Commun 2007;357:414-420.
22. Jiang J, Au M, Lu K et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 2007;25:1940-1953.
23. Kroon E, Martinson LA, Kadoya K et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008;26:397-398.
24. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
25. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society For Cellular Therapy Position Statement. Cytotherapy 2006;8:315-317.
26. Thomas S, Thomas M, Wincker P et al. Human neural crest cells display molecular and phenotypic hallmarks of stem cells. Hum Mol Genet 2008;17:3411-3425.
27. Safford KM, Hiock KC, Safford SD et al. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 2002;294:371-379.
28. Guilak F, Lott KE, Awad HA et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 2006;206:229-237.
29. Dhar S, Yoon ES, Kachgal S et al. Long-term maintenance of neuronally differentiated human adipose tissue-derived stem cells. Tissue Eng 2007;13:2625-2632.
30. Anghileri E, Marconi S, Pignatelli A et al. Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. Stem Cells Dev 2008;17:909-916.
31. Billon N, Iannarelli P, Monteiro MC et al. The generation of adipocytes by the neural crest. Development 2007;134:2283-2292.
32. Takashima Y, Era T, Nakao K et al. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007;129:1377-1388.
33. Wrage PC, Tran T, To K et al. The neuro-glial properties of adipose-derived adult stromal (ADAS) cells are not regulated by Notch 1 and are not derived from neural crest lineage. Plos One 2008;3:e1453.
34. Grinnemo KH, Månsson A, Dellgren G et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg 2004;127:1293-1300.
35. Drukker M, Katchman H, Katz G et al. Human embryonic stem cells and their differentiated derivatives are less susceptible for immune rejection than adult cells. Stem Cells 2006;24:221-229.
36. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008;8:726-736.
37. Rajagopal J, Anderson WJ, Kume S et al. Insulin staining of ES cell progeny from insulin uptake. Science 2003;299:363.
38. Hansson M, Tonning A, Frandsen U et al. Artifactual insulin release form differentiated embryonic stem cells. Diabetes 2004;53:2603-2609.
39. D'Amour KA, Bang AG, Eliazer S et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006;24:1392-1401.
40. Edlund H. Pancreatic organogenesis-developmental mechanisms and implications for therapy. Nat Rev Genet 2002;3:524-532.
41. Niehof M, Borlak J. RSK4 and PAK5 are novel candidate genes in diabetic rat kidney and brain. Mol Pharmacol 2005;67:604-611.
42. During MJ, Cao L, Zuzga DS et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 2003;9:1173-1179.
43. Kang L, Dunn-Meynell AA, Routh VH et al. Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes 2006;55:412-420.
44. Hori Y, Gu X, Xie X et al. Differentiation of insulin-producing cells from human neural progenitor cells. Plos Med 2005;2:e103.
45. Choi Y, Ta M, Atouf F et al. Adult pancreas generates multipotent stem cells and pancreatic and nonpancreatic progeny. Stem Cells 2004;22:1070-1084.
46. Seaberg RM, Smukler SR, Kieffer TJ et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 2004;22:1115-1124.
47. Otonkoski T, Beattie GM, Mally MI et al. Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells. J Clin Invest 1993;92:1459-1466.
48. Demeterco C, Beattie GM, Dib SA et al. A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab 2000;85:3892-3897.
49. Farilla L, Bulotta A, Hirshberg B et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 2003;144:5149-5158.
50. Segev H, Fishman B, Ziskind A et al. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 2004;22:265-274.